CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....
Phase 1
Pittsburgh, Pennsylvania, United States and 6 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Pittsburgh, Pennsylvania, United States and 71 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 41 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Pittsburgh, Pennsylvania, United States and 56 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 33 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 84 other locations
1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for whic...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 4 other locations
inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor ac...
Phase 1
Pittsburgh, Pennsylvania, United States and 21 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Pittsburgh, Pennsylvania, United States and 226 other locations
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal